$18+M Revenue/quater is very good since its less than year
How many company get near $80 million runrate within 1 year. This is great drug and will reach half billion may be more within next 4-5 year. Which mean this company will worth 40-50 dollar at that time.
you are not going to make large gain overnight but in long term this stock will provide very sweet return. And also has great safety at current price compare to other biotech.
vs1234gs,,,,you sound like a china man extremely concerned and panicking about OPTR, lol. Did u get swindled and own a lot? Perhaps an insider, lol! OPTR will be heading back to 7pps as the economics do not support current valuation.